Hillsdale Investment Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-6,570
| Closed | -$524K | – | 600 |
|
|
2024
Q1 | $524K | Sell |
6,570
-400
| -6% | -$30.6K | 0.04% | 314 |
|
|
2023
Q4 | $550K | Buy |
6,970
+30
| +0.4% | +$2.13K | 0.04% | 271 |
|
|
2023
Q3 | $485K | Buy |
6,940
+404
| +6% | +$28.6K | 0.04% | 285 |
|
|
2023
Q2 | $452K | Sell |
6,536
-1,230
| -16% | -$87.5K | 0.04% | 271 |
|
|
2023
Q1 | $577K | Buy |
7,766
+6,590
| +560% | +$553K | 0.05% | 286 |
|
|
2022
Q4 | $110K | Sell |
1,176
-40
| -3% | -$3.86K | 0.01% | 438 |
|
|
2022
Q3 | $116K | Sell |
1,216
-569
| -32% | -$56.3K | 0.01% | 412 |
|
|
2022
Q2 | $165K | Buy |
1,785
+223
| +14% | +$21.8K | 0.01% | 404 |
|
|
2022
Q1 | $158K | Buy |
1,562
+1,002
| +179% | +$105K | 0.01% | 409 |
|
|
2021
Q4 | $58K | Hold |
560
| – | – | ﹤0.01% | 483 |
|
|
2021
Q3 | $48K | Sell |
560
-20
| -3% | -$1.68K | ﹤0.01% | 487 |
|
|
2021
Q2 | $48K | Buy |
+580
| New | +$47.5K | ﹤0.01% | 467 |
|
|
2020
Q3 | – | Sell |
-740
| Closed | -$48K | – | 592 |
|
|
2020
Q2 | $48K | Buy |
740
+120
| +19% | +$7.56K | ﹤0.01% | 428 |
|
|
2020
Q1 | $37K | Hold |
620
| – | – | ﹤0.01% | 448 |
|
|
2019
Q4 | $46K | Hold |
620
| – | – | ﹤0.01% | 442 |
|
|
2019
Q3 | $39K | Buy |
+620
| New | +$36.7K | ﹤0.01% | 458 |
|
|
2018
Q3 | – | Sell |
-700
| Closed | -$45K | – | 488 |
|
|
2018
Q2 | $45K | Hold |
700
| – | – | 0.01% | 320 |
|
|
2018
Q1 | $44K | Sell |
700
-5,400
| -89% | -$387K | 0.01% | 307 |
|
|
2017
Q4 | $443K | Buy |
+6,100
| New | +$443K | 0.07% | 217 |
|
|
2017
Q1 | – | Sell |
-15
| Closed | -$1K | – | 485 |
|
|
2016
Q4 | $1K | Sell |
15
-25
| -63% | -$2.02K | ﹤0.01% | 470 |
|
|
2016
Q3 | $4K | Buy |
40
+20
| +100% | +$1.89K | ﹤0.01% | 421 |
|
|
2016
Q2 | $2K | Sell |
20
-2,690
| -99% | -$268K | ﹤0.01% | 471 |
|
|
2016
Q1 | $281K | Sell |
2,710
-20
| -0.7% | -$1.95K | 0.1% | 277 |
|
|
2015
Q4 | $267K | Buy |
2,730
+20
| +0.7% | +$1.96K | 0.1% | 278 |
|
|
2015
Q3 | $261K | Sell |
2,710
-500
| -16% | -$52.6K | 0.09% | 245 |
|
|
2015
Q2 | $337K | Buy |
3,210
+110
| +4% | +$11.2K | 0.1% | 198 |
|
|
2015
Q1 | $320K | Buy |
+3,100
| New | +$314K | 0.08% | 274 |
|
|
2013
Q4 | – | Sell |
-5,220
| Closed | -$296K | – | 542 |
|
|
2013
Q3 | $296K | Hold |
5,220
| – | – | 0.09% | 199 |
|
|
2013
Q2 | $298K | Buy |
+5,220
| New | +$302K | 0.1% | 177 |
|
Other funds holding CVS
Hillsdale Investment Management's CVS Position: Q2 2024 in Review
Hillsdale Investment Management sold out of CVS Health (CVS) in Q2 2024, closing a stake of 6,570 shares — an estimated $524K sold.
Hillsdale Investment Management first reported a position in CVS in Q2 2013 and held it in 29 quarters. The position peaked at $577K in Q1 2023. 1,911 funds tracked by Wall St. Rank hold CVS as of Q2 2024.
- Hillsdale Investment Management reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
- Hillsdale Investment Management sold 6,570 CVS Health shares in Q2 2024, an estimated $524K.
- Hillsdale Investment Management first reported a position in CVS Health in Q2 2013 and held it in 29 quarters.
- Hillsdale Investment Management's CVS Health position peaked at $577K in Q1 2023.
- 1,911 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.
Based on Hillsdale Investment Management's 13F filing for Q2 2024, filed 13 Aug 2024.